Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Red Rock Fertility Center.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Watson Pharmaceuticals
Information provided by (Responsible Party):
Red Rock Fertility Center
ClinicalTrials.gov Identifier:
NCT01513954
First received: January 17, 2012
Last updated: NA
Last verified: January 2012
History: No changes posted

January 17, 2012
January 17, 2012
January 2012
January 2013   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration

The purpose of this study is to determine whether progesterone hormone levels differ following egg retrieval with a single lumen needle compared with a double lumen needle. These levels will be measured on several days before and after egg retrieval. The progesterone levels in each IVF group will also be compared to the group of women who are having IUI. In addition, these progesterone levels will be correlated with pregnancy outcomes.

This is a prospective randomized trial consisting of 3 groups of patients. Following a long lupron protocol IVF cycle there is a need for supplemental progesterone. The purpose of this study is to determine what range of serum levels should be observed when differing methods of egg aspiration have been administered and whether or not there is a correlation with outcomes or pregnancies.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

IUI patients and IVF patients following a long lupron protocol cycle

Infertility, Female
Not Provided
  • IVF population
    Long Lupron IVF Population
  • IUI patients
    Patients undergoing IUI
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
450
June 2013
January 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages between 21-37
  • Cycle Day 3 FSH between 2-12
  • History of regular menstrual cycles between 24-34 days

Exclusion Criteria:

  • Previous IVF failure
  • Severe male factor
  • Severe obesity, BMI > 40
  • More than 20 follicles on ultrasound prior to retrieval
Female
21 Years to 37 Years
Yes
Contact: Eva D Littman, M.D. 702-262-0079 drevalittman@hotmail.com
Contact: Maria (Charry) R Lopez, M.D. 702-262-0079 charry@lasvegasfertility.com
United States
 
NCT01513954
20111821
Yes
Red Rock Fertility Center
Red Rock Fertility Center
Watson Pharmaceuticals
Principal Investigator: Eva D Littman, M.D. Red Rock Fertility Center
Red Rock Fertility Center
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP